<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Blood Disord</journal-id><journal-title>BMC Blood Disorders</journal-title><issn pub-type="epub">1471-2326</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16732890</article-id><article-id pub-id-type="pmc">1481503</article-id><article-id pub-id-type="publisher-id">1471-2326-6-2</article-id><article-id pub-id-type="doi">10.1186/1471-2326-6-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>The effect of an exercise intervention on aerobic fitness, strength and quality of life in children with haemophilia (ACTRN012605000224628)</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Broderick</surname><given-names>Carolyn R</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>c.broderick@unsw.edu.au</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Herbert</surname><given-names>Robert D</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>r.herbert@fhs.usyd.edu.au</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Latimer</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>j.latimer@fhs.usyd.edu.au</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Curtin</surname><given-names>Julie A</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>juliec3@chw.edu.au</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Selvadurai</surname><given-names>Hiran C</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>hirans@chw.edu.au</email></contrib></contrib-group><aff id="I1"><label>1</label>School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney 2052, Australia</aff><aff id="I2"><label>2</label>Children's Hospital Institute of Sports Medicine, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia</aff><aff id="I3"><label>3</label>School of Physiotherapy, University of Sydney, Lidcombe NSW 1825, Australia</aff><aff id="I4"><label>4</label>Department of Haematology, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia</aff><aff id="I5"><label>5</label>Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>29</day><month>5</month><year>2006</year></pub-date><volume>6</volume><fpage>2</fpage><lpage>2</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2326/6/2"></ext-link><history><date date-type="received"><day>12</day><month>3</month><year>2006</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2006</year></date></history><permissions><copyright-statement>Copyright © 2006 Broderick et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Broderick et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3859" xml_f="3869" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3880" xml_f="4148" txt_i="22" txt_f="290">Children with haemophilia have lower levels of fitness and strength than their healthy peers. We present the protocol of a study designed to determine whether an exercise intervention improves quality of life, aerobic fitness and strength in children with haemophilia.</offsets></p></sec><sec><title><offsets xml_i="4170" xml_f="4184" txt_i="292" txt_f="306">Methods/Design</offsets></title><p><offsets xml_i="4195" xml_f="4716" txt_i="307" txt_f="828">The study will be a randomised, assessor-blinded, controlled trial of exercise treatment. Seventy children aged between 6 and 18 years with haemophilia or von Willebrand disease will be recruited from two paediatric haemophilia clinics in NSW. Each participant will be allocated to an exercise group or a control group using a concealed allocation procedure. The control group will receive usual medical care while the intervention group will receive usual medical care plus an exercise program for 12 weeks. Outcomes (VO</offsets><sub><offsets xml_i="4721" xml_f="4726" txt_i="828" txt_f="833">2peak</offsets></sub><offsets xml_i="4732" xml_f="5120" txt_i="833" txt_f="1221">, knee extensor strength and quality of life) will be measured at baseline and on completion of the exercise program by a blinded assessor. The primary analysis will be conducted on an intention to treat basis. The effects of the exercise intervention on each of the three primary outcomes will be estimated from between-group differences in the mean outcome adjusted for baseline scores.</offsets></p></sec><sec><title><offsets xml_i="5142" xml_f="5152" txt_i="1223" txt_f="1233">Discussion</offsets></title><p><offsets xml_i="5163" xml_f="5336" txt_i="1234" txt_f="1407">This study will be the first randomised controlled trial to examine the effects of a structured exercise program on fitness and quality of life in children with haemophilia.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="5398" xml_f="5408" txt_i="1416" txt_f="1426">Background</offsets></title><p><offsets xml_i="5419" xml_f="5517" txt_i="1427" txt_f="1525">Haemophilia A and B are X-linked recessive conditions which affect 1 in 7,000 males in Australia [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="5548" xml_f="5549" txt_i="1525" txt_f="1526">1</offsets></xref><offsets xml_i="5556" xml_f="6328" txt_i="1526" txt_f="2292">]. They are characterised by deficiency of Factor VIII or Factor IX (in the mild and moderate forms) and absence of Factor VIII or IX (in the severe form). Haemophilia is characterised by an increased bleeding tendency, the severity of which is dependent on the absolute levels of Factor VIII or IX. Mild haemophilia (when the factor level is 5–40%) is rarely associated with spontaneous bleeds. Moderate haemophilia means that the factor level is &lt;5% of normal and severe haemophilia occurs when the factor level is &lt;1%. The hallmarks of haemophilia are intramuscular and intra-articular bleeds. Some children develop "target joints" characterised by multiple bleeds into the same joint which can lead to destruction of the joint surfaces (haemophilic arthropathy).</offsets></p><p><offsets xml_i="6335" xml_f="6853" txt_i="2293" txt_f="2811">In the past, children with haemophilia were often discouraged from physical activity due to a concern that this would increase the risk of haemarthroses. The availability of recombinant factor XIII has meant that children with severe haemophilia can now have prophylactic therapy to prevent spontaneous bleeds. A multi-centre study comparing prophylactic therapy with on-demand treatment in young adults with severe haemophilia demonstrated fewer joint bleeds and lower levels of arthropathy in the prophylaxis group [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6884" xml_f="6885" txt_i="2811" txt_f="2812">2</offsets></xref><offsets xml_i="6892" xml_f="6894" txt_i="2812" txt_f="2814">].</offsets></p><p><offsets xml_i="6901" xml_f="7156" txt_i="2815" txt_f="3070">Even though children with haemophilia are now advised to participate in physical activity, a number of studies, including recent studies, have suggested that these children have lower levels of fitness and strength when compared with their healthy peers [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="7187" xml_f="7188" txt_i="3070" txt_f="3071">3</offsets></xref><offsets xml_i="7195" xml_f="7196" txt_i="3071" txt_f="3072">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7227" xml_f="7228" txt_i="3072" txt_f="3073">4</offsets></xref><offsets xml_i="7235" xml_f="7487" txt_i="3073" txt_f="3325">]. Unfortunately, these studies have used samples that are not representative (they sample small numbers of volunteers from haemophilia clinics) and it therefore remains unclear whether children with haemophilia do in fact have lower levels of fitness.</offsets></p><p><offsets xml_i="7494" xml_f="7773" txt_i="3326" txt_f="3605">The therapeutic role of exercise in children with haemophilia has not been well documented but there is some evidence that exercise can improve coagulation parameters. Factor VIII levels have been shown to increase after a single strenuous bout of exercise in non-haemophiliacs [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7804" xml_f="7805" txt_i="3605" txt_f="3606">5</offsets></xref><offsets xml_i="7812" xml_f="7813" txt_i="3606" txt_f="3607">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7844" xml_f="7845" txt_i="3607" txt_f="3608">6</offsets></xref><offsets xml_i="7852" xml_f="8002" txt_i="3608" txt_f="3758">]. A modest improvement in coagulation parameters after an acute bout of exercise has also been shown in children with mild and moderate haemophilia [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="8033" xml_f="8034" txt_i="3758" txt_f="3759">7</offsets></xref><offsets xml_i="8041" xml_f="8376" txt_i="3759" txt_f="4094">]. Whether this improvement in coagulation parameters correlates with frequency and severity of bleeding episodes remains unclear. One pilot study which examined the effect of resistance training on 5 adults with haemophilia reported this type of training improved strength and reduced the frequency and severity of bleeding episodes [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8407" xml_f="8408" txt_i="4094" txt_f="4095">8</offsets></xref><offsets xml_i="8415" xml_f="8638" txt_i="4095" txt_f="4318">]. However, the findings of this small and uncontrolled study cannot be considered reliable. The effects of resistance training on frequency and severity of bleeds needs to be tested in a larger randomised controlled trial.</offsets></p><p><offsets xml_i="8645" xml_f="8810" txt_i="4319" txt_f="4484">Studies which report positive effects from an exercise intervention in adults with haemophilia have had very small subject numbers and lacked experimental controls [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8841" xml_f="8842" txt_i="4484" txt_f="4485">8</offsets></xref><offsets xml_i="8849" xml_f="8868" txt_i="4485" txt_f="4504">]. Hilberg et al. [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8899" xml_f="8900" txt_i="4504" txt_f="4505">9</offsets></xref><offsets xml_i="8907" xml_f="8981" txt_i="4505" txt_f="4579">] documented improvements in isometric leg strength and proprioception in </offsets><italic><offsets xml_i="8989" xml_f="8996" txt_i="4579" txt_f="4586">adults </offsets></italic><offsets xml_i="9005" xml_f="9217" txt_i="4586" txt_f="4798">with severe haemophilia following a physical training programme, but this study had small numbers and was not randomised and therefore gives limited information about the effect of exercise on muscle performance.</offsets></p><p><offsets xml_i="9224" xml_f="9479" txt_i="4799" txt_f="5054">Finally, the effect of an exercise programme on quality of life in children with haemophilia has yet to be examined. In other chronic diseases in children, however, exercise interventions have shown positive effects on quality of life. Selvadurai et al. [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="9511" xml_f="9513" txt_i="5054" txt_f="5056">10</offsets></xref><offsets xml_i="9520" xml_f="9817" txt_i="5056" txt_f="5353">] reported improvements in quality of life, as measured by the Quality of Well Being Scale, in children with cystic fibrosis following an in-hospital aerobic exercise programme. Recently a disease-specific quality of life questionnaire (Haemo-QoL) has been validated in children with haemophilia [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="9849" xml_f="9851" txt_i="5353" txt_f="5355">11</offsets></xref><offsets xml_i="9858" xml_f="9859" txt_i="5355" txt_f="5356">-</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="9891" xml_f="9893" txt_i="5356" txt_f="5358">13</offsets></xref><offsets xml_i="9900" xml_f="9978" txt_i="5358" txt_f="5436">]. The effect of an exercise programme on quality of life can now be assessed.</offsets></p><p><offsets xml_i="9985" xml_f="10251" txt_i="5437" txt_f="5703">The primary aim of this study is to determine the effects of exercise on aerobic fitness, strength and quality of life in children with haemophilia. A secondary aim is to examine the effect of an exercise programme on the frequency and severity of bleeding episodes.</offsets></p></sec><sec><title><offsets xml_i="10273" xml_f="10285" txt_i="5705" txt_f="5717">Study design</offsets></title><p><offsets xml_i="10296" xml_f="10663" txt_i="5718" txt_f="6085">This study will be a randomised, assessor-blinded, controlled trial of exercise treatment for children with haemophilia. The control group will receive usual medical care while the intervention group will receive a general exercise program of 12 weeks duration. Outcomes will be measured at baseline, on completion of the exercise program at 3 months and at 6 months.</offsets></p><p><offsets xml_i="10670" xml_f="11412" txt_i="6086" txt_f="6828">Seventy children with Haemophilia A or B or von Willebrand disease who are currently managed through the haematology clinic at The Children's Hospital at Westmead and Sydney Children's Hospital will be recruited. To participate in the study children must be aged between 6 and 18 years, have a diagnosis of mild, moderate or severe haemophilia (A or B) or von Willebrand disease and the parent/guardian and child must agree to accept randomisation to either intervention or control group. Subjects will be excluded if they have any contraindication to aerobic or resistance training. Children who are already involved in regular, organised physical activity lasting greater than 1 hour for more than 3 sessions per week will also be excluded.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="11453" xml_f="11460" txt_i="6830" txt_f="6837">Methods</offsets></title><p><offsets xml_i="11471" xml_f="11894" txt_i="6838" txt_f="7261">Following the screening consultation, baseline measures will be collected by the researcher. All children will have baseline anthropometric data recorded (height, weight, BMI, and body fat using bioelectrical impedance). They will then undergo fitness testing. This will consist of tests of grip strength and isokinetic strength testing to assess quadriceps and hamstrings strength in the non-dominant leg. In addition a VO</offsets><sub><offsets xml_i="11899" xml_f="11905" txt_i="7261" txt_f="7267">2peak </offsets></sub><offsets xml_i="11911" xml_f="12045" txt_i="7267" txt_f="7401">test will be performed using a treadmill protocol. All subjects or their parents/guardians will complete the Haemo-QoL questionnaire [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="12077" xml_f="12079" txt_i="7401" txt_f="7403">13</offsets></xref><offsets xml_i="12086" xml_f="12139" txt_i="7403" txt_f="7456">] and the Habitual Activity Estimation Scale (HAES) [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="12171" xml_f="12173" txt_i="7456" txt_f="7458">14</offsets></xref><offsets xml_i="12180" xml_f="12388" txt_i="7458" txt_f="7666">]. The HAES questionnaire will be used to explain effects of exercise, should they be apparent, and to determine whether completing a structured 12 week exercise program increases levels of habitual activity.</offsets></p><p><offsets xml_i="12395" xml_f="13204" txt_i="7667" txt_f="8476">A randomisation schedule will be created with computer-generated random numbers by a person not otherwise involved in the recruitment process. The allocation will be in randomly permuted blocks of 4, 6 and 8. Allocations will be placed in sequentially numbered, sealed, opaque envelopes to ensure concealment from the researchers recruiting subjects, and from the subjects themselves, prior to randomisation. Potential subjects (or the guardians of subjects) will be invited to participate in the study and the methods of the study will be explained to them verbally and in writing. If they agree to participate baseline measures will be obtained before the subject is randomised to a group. Subjects will be considered to have entered the trial at the time the envelope containing their allocation is opened.</offsets></p><p><offsets xml_i="13211" xml_f="13231" txt_i="8477" txt_f="8497">Participants in the </offsets><bold><offsets xml_i="13237" xml_f="13251" txt_i="8497" txt_f="8511">control group </offsets></bold><offsets xml_i="13258" xml_f="13803" txt_i="8511" txt_f="9056">will receive usual medical care by their treating haematologist and associated health practitioners. Their management will include factor therapy (prophylaxis or "on demand"), as determined by their treating haematologist. All parents will have been educated about the disease and been taught how to recognise a bleeding episode. For the purposes of this study when defining a bleeding episode we have accepted the definition widely used by other researchers that is, a bleed is "an episode of bleeding requiring treatment with clotting factor"[</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="13835" xml_f="13837" txt_i="9056" txt_f="9058">15</offsets></xref><offsets xml_i="13844" xml_f="14006" txt_i="9058" txt_f="9220">]. Parents will be encouraged to treat bleeding episodes as soon as recognized and advice about duration of therapy will be given by their treating haematologist.</offsets></p><p><offsets xml_i="14013" xml_f="14033" txt_i="9221" txt_f="9241">Participants in the </offsets><bold><offsets xml_i="14039" xml_f="14054" txt_i="9241" txt_f="9256">exercise group </offsets></bold><offsets xml_i="14061" xml_f="14492" txt_i="9256" txt_f="9687">will receive a supervised, general exercise program in addition to their usual medical care. The exercise program will be conducted for 1 hour, two times per week for 12 weeks. The program will consist of a supervised "circuit training" programme including warm-up and warm-down and an age-appropriate mix of resistance exercises and aerobic stations. Aerobic training will consist of 30 minutes of continuous exercise at 60–70% HR</offsets><sub><offsets xml_i="14497" xml_f="14500" txt_i="9687" txt_f="9690">max</offsets></sub><offsets xml_i="14506" xml_f="14575" txt_i="9690" txt_f="9759">, depending on baseline fitness of the participant, as measured by VO</offsets><sub><offsets xml_i="14580" xml_f="14586" txt_i="9759" txt_f="9765">2peak </offsets></sub><offsets xml_i="14592" xml_f="15075" txt_i="9765" txt_f="10248">test. Resistance training will follow the traditional "set system" and involve 20 minutes of upper and lower limb exercises using isotonic pin-loaded equipment. The training load will be set at the 8–12 repetition maximum (RM). Subjects will perform 3 sets, each to failure, with the 8–12 RM load. Throughout the training period the load will be incremented so that failure occurs at between 8 and 12 repetitions. Ten minutes per session will involve warm-up and warm-down exercises[</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="15107" xml_f="15109" txt_i="10248" txt_f="10250">16</offsets></xref><offsets xml_i="15116" xml_f="15530" txt_i="10250" txt_f="10664">]. The exercise sessions will be changed frequently to avoid boredom. Patients receiving prophylactic Factor VIII will administer this prior to the exercise intervention. A qualified paediatric physical therapist will conduct and supervise the exercise program. The therapist will undergo additional training in the aetiology and management of haemophilia and understand the early management of a bleeding episode.</offsets></p><p><offsets xml_i="15537" xml_f="16355" txt_i="10665" txt_f="11483">Participants in the control group will be advised not to change their physical activity levels during the course of the trial. In cases where this is unavoidable, a record of the changes will be kept. Several mechanisms will be used to ensure that the trial protocol is consistently applied. Protocol manuals will be developed and the researchers (haematologists, physical therapists, exercise physiologists, other outcome assessors and the trial manager) will be trained to ensure that screening, outcome assessment, allocation and treatment protocols are conducted according to the protocol. An independent researcher will randomly audit assessment and treatment sessions to determine adherence to the protocol. Retraining will be offered to treatment providers and outcome assessors not complying with the protocol.</offsets></p><sec><title><offsets xml_i="16371" xml_f="16379" txt_i="11484" txt_f="11492">Outcomes</offsets></title><p><offsets xml_i="16390" xml_f="16493" txt_i="11493" txt_f="11596">The primary outcomes will be quality of life, strength and aerobic fitness. The details are as follows:</offsets></p><p><offsets xml_i="16500" xml_f="16503" txt_i="11597" txt_f="11600">1. </offsets><bold><offsets xml_i="16509" xml_f="16525" txt_i="11600" txt_f="11616">Quality of Life </offsets></bold><offsets xml_i="16532" xml_f="16635" txt_i="11616" txt_f="11719">using the Haemo-QoL questionnaire. This questionnaire has been validated in children with haemophilia [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="16667" xml_f="16669" txt_i="11719" txt_f="11721">13</offsets></xref><offsets xml_i="16676" xml_f="16677" txt_i="11721" txt_f="11722">]</offsets></p><p><offsets xml_i="16684" xml_f="16687" txt_i="11723" txt_f="11726">2. </offsets><bold><offsets xml_i="16693" xml_f="16713" txt_i="11726" txt_f="11746">Quadriceps strength </offsets></bold><offsets xml_i="16720" xml_f="16758" txt_i="11746" txt_f="11784">using a Cybex isokinetic dynamometer [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="16790" xml_f="16792" txt_i="11784" txt_f="11786">17</offsets></xref><offsets xml_i="16799" xml_f="16800" txt_i="11786" txt_f="11787">]</offsets></p><p><offsets xml_i="16807" xml_f="16810" txt_i="11788" txt_f="11791">3. </offsets><bold><offsets xml_i="16816" xml_f="16818" txt_i="11791" txt_f="11793">VO</offsets><sub><offsets xml_i="16823" xml_f="16829" txt_i="11793" txt_f="11799">2peak </offsets></sub></bold><offsets xml_i="16842" xml_f="16878" txt_i="11799" txt_f="11835">using the Bruce treadmill protocol [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="16910" xml_f="16912" txt_i="11835" txt_f="11837">18</offsets></xref><offsets xml_i="16919" xml_f="16920" txt_i="11837" txt_f="11838">]</offsets></p><p><offsets xml_i="16927" xml_f="16931" txt_i="11839" txt_f="11843">The </offsets><italic><offsets xml_i="16939" xml_f="16949" txt_i="11843" txt_f="11853">secondary </offsets></italic><offsets xml_i="16958" xml_f="16982" txt_i="11853" txt_f="11877">outcomes are as follows:</offsets></p><p><offsets xml_i="16989" xml_f="16992" txt_i="11878" txt_f="11881">1. </offsets><bold><offsets xml_i="16998" xml_f="17050" txt_i="11881" txt_f="11933">Incidence of haemarthroses and intramuscular bleeds </offsets></bold><offsets xml_i="17057" xml_f="17137" txt_i="11933" txt_f="12013">– self-reported for 16 weeks (12 week intervention period and 4 weeks following)</offsets></p><p><offsets xml_i="17144" xml_f="17147" txt_i="12014" txt_f="12017">2. </offsets><bold><offsets xml_i="17153" xml_f="17180" txt_i="12017" txt_f="12044">Lean tissue mass, body fat </offsets></bold><offsets xml_i="17187" xml_f="17256" txt_i="12044" txt_f="12113">measured using bioelectrical impedance on a body composition analyser</offsets></p><p><offsets xml_i="17263" xml_f="17266" txt_i="12114" txt_f="12117">3. </offsets><bold><offsets xml_i="17272" xml_f="17290" txt_i="12117" txt_f="12135">Habitual activity </offsets></bold><offsets xml_i="17297" xml_f="17323" txt_i="12135" txt_f="12161">using HAES questionnaire [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="17355" xml_f="17357" txt_i="12161" txt_f="12163">14</offsets></xref><offsets xml_i="17364" xml_f="17365" txt_i="12163" txt_f="12164">]</offsets></p><p><offsets xml_i="17372" xml_f="17375" txt_i="12165" txt_f="12168">4. </offsets><bold><offsets xml_i="17381" xml_f="17404" txt_i="12168" txt_f="12191">Other strength measures</offsets></bold></p><p><offsets xml_i="17418" xml_f="17487" txt_i="12192" txt_f="12261">- Isokinetic hamstrings strength using a Cybex isokinetic dynamometer</offsets></p><p><offsets xml_i="17494" xml_f="17536" txt_i="12262" txt_f="12304">- Grip strength using a hand dynamometer [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="17568" xml_f="17570" txt_i="12304" txt_f="12306">19</offsets></xref><offsets xml_i="17577" xml_f="17578" txt_i="12306" txt_f="12307">]</offsets></p><p><offsets xml_i="17585" xml_f="17588" txt_i="12308" txt_f="12311">5. </offsets><bold><offsets xml_i="17594" xml_f="17609" txt_i="12311" txt_f="12326">Adverse events </offsets></bold><offsets xml_i="17616" xml_f="17739" txt_i="12326" txt_f="12449">(other than haemarthroses) associated with exercise or physical activity. These will be elicited by open-ended questioning.</offsets></p><p><offsets xml_i="17746" xml_f="18200" txt_i="12450" txt_f="12904">All measurements will be taken immediately after the 12 week intervention period, by an assessor blind to group allocation. (The exception is measurement of bleeding episodes, which will be monitored as described above.) Habitual activity and quality of life will be re-measured in a telephone interview at six months. The number and type of any adverse effects that occur for the duration of the study will also be recorded using open-ended questioning.</offsets></p><p><offsets xml_i="18207" xml_f="18826" txt_i="12905" txt_f="13524">In order to improve compliance and reduce loss to follow-up, participants in the intervention and control groups will be telephoned at the beginning of each week. Participants in the both groups will be asked about bleeding episodes in the previous week. In addition, participants in the intervention group will be reminded of their exercise training schedule. All participants will be asked to keep a diary to record all bleeding episodes during and for one month following the intervention period. The final data on number of bleeds will be a composite of the data obtained from diaries and from telephone follow-ups.</offsets></p></sec><sec><title><offsets xml_i="18848" xml_f="18878" txt_i="13526" txt_f="13556">Sample size and power analysis</offsets></title><p><offsets xml_i="18889" xml_f="19099" txt_i="13557" txt_f="13767">A sample size of 70 subjects (35 subjects per group) will provide an 80% probability of detecting an effect of 0.75 standard deviations on H-QOL scale assuming α of 0.05 and worst-case loss to follow up of 15%.</offsets></p></sec><sec><title><offsets xml_i="19121" xml_f="19134" txt_i="13769" txt_f="13782">Data analysis</offsets></title><p><offsets xml_i="19145" xml_f="20001" txt_i="13783" txt_f="14639">Data will be analysed by a statistician who is blinded to group. All analyses will be by intention to treat. That is, outcome data will be collected regardless of compliance with the trial protocol, and each patient's data will be analysed in the group to which the subject was allocated. The effect of exercise will be estimated with analysis of covariance using a regression approach. To maximise the precision of estimates, pre-test scores of outcome variables will be entered into the regression models as covariates. The uncertainty associated with estimates of the size of effects of exercise will be quantified with 95% confidence intervals. The integrity of the trial data will be monitored by regular scrutiny of data sheets for omissions and errors. Data will be double entered and the source of any inconsistencies will be explored and resolved.</offsets></p></sec></sec><sec><title><offsets xml_i="20029" xml_f="20039" txt_i="14642" txt_f="14652">Discussion</offsets></title><p><offsets xml_i="20050" xml_f="20753" txt_i="14653" txt_f="15356">We have presented the rationale and design for an RCT examining the effects of exercise on quality of life, fitness and strength in children with haemophilia. This study has been designed to include key methodological features recognised to minimise bias in clinical trials. These features include: true randomisation using concealed allocation, blind outcome assessment, blind analysis of results and intention-to-treat analyses. We have also included practical measures to minimise the number of dropouts and maximise compliance with the trial protocol. The results of this trial will be available in 2008 and will provide important information likely to affect the lives of children with haemophilia.</offsets></p></sec><sec><title><offsets xml_i="20775" xml_f="20788" txt_i="15358" txt_f="15371">Abbreviations</offsets></title><p><offsets xml_i="20799" xml_f="20820" txt_i="15372" txt_f="15393">BMI – body mass index</offsets></p><p><offsets xml_i="20827" xml_f="20868" txt_i="15394" txt_f="15435">HAES – Habitual Activity Estimation Scale</offsets></p><p><offsets xml_i="20875" xml_f="20902" txt_i="15436" txt_f="15463">HR max – maximum heart rate</offsets></p><p><offsets xml_i="20909" xml_f="20962" txt_i="15464" txt_f="15517">Haemo-QoL – Haemophilia quality of life questionnaire</offsets></p><p><offsets xml_i="20969" xml_f="20992" txt_i="15518" txt_f="15541">RM – repetition maximum</offsets></p><p><offsets xml_i="20999" xml_f="21033" txt_i="15542" txt_f="15576">VO2 peak – peak oxygen consumption</offsets></p></sec><sec><title><offsets xml_i="21055" xml_f="21074" txt_i="15578" txt_f="15597">Competing interests</offsets></title><p><offsets xml_i="21085" xml_f="21145" txt_i="15598" txt_f="15658">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="21167" xml_f="21189" txt_i="15660" txt_f="15682">Authors' contributions</offsets></title><p><offsets xml_i="21200" xml_f="21540" txt_i="15683" txt_f="16023">CB conceived the study and was involved in study design and preparation of the manuscript. RH was involved in study design. JL contributed to study design, design of the intervention and preparation of the manuscript. HS was involved in design of the clinical intervention and JC provided advice regarding care of children with haemophilia.</offsets></p><p><offsets xml_i="21547" xml_f="21598" txt_i="16024" txt_f="16075">All authors read and approved the final manuscript.</offsets></p></sec><sec><title><offsets xml_i="21620" xml_f="21643" txt_i="16077" txt_f="16100">Pre-publication history</offsets></title><p><offsets xml_i="21654" xml_f="21718" txt_i="16101" txt_f="16165">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2326/6/2/prepub"></ext-link></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>AM</given-names></name><name><surname>Ekert</surname><given-names>H</given-names></name></person-group><article-title>Haemophilia--darkest hours before the dawn.[see comment]</article-title><source>Med J Aust</source><year>1996</year><volume>164</volume><fpage>453</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">8614331</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>van der Bom</surname><given-names>JG</given-names></name><name><surname>Molho</surname><given-names>P</given-names></name><name><surname>Negrier</surname><given-names>C</given-names></name><name><surname>Mauser-Bunschoten</surname><given-names>EP</given-names></name><name><surname>Roosendaal</surname><given-names>G</given-names></name><name><surname>De Kleijn</surname><given-names>P</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>van den Berg</surname><given-names>HM</given-names></name></person-group><article-title>Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome</article-title><source>Haemophilia</source><year>2002</year><volume>8</volume><fpage>745</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">12410642</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2516.2002.00695.x</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>B</given-names></name><name><surname>Portal</surname><given-names>S</given-names></name><name><surname>Tiktinsky</surname><given-names>R</given-names></name><name><surname>Weinstein</surname><given-names>Y</given-names></name><name><surname>Constantini</surname><given-names>N</given-names></name><name><surname>Martinowitz</surname><given-names>U</given-names></name></person-group><article-title>Anaerobic power and muscle strength in young hemophilia patients</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>32</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">10647529</pub-id><pub-id pub-id-type="doi">10.1097/00005768-200001000-00009</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>B</given-names></name><name><surname>Galioto</surname><given-names>FMJ</given-names></name><name><surname>Kelleher</surname><given-names>J</given-names></name><name><surname>Goldstein</surname><given-names>D</given-names></name></person-group><article-title>Physical fitness in children with hemophilia</article-title><source>Arch Phys Med Rehabil</source><year>1984</year><volume>65</volume><fpage>324</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">6732461</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>M</given-names></name><name><surname>Carter</surname><given-names>C</given-names></name><name><surname>O'Brodovich</surname><given-names>H</given-names></name><name><surname>Heigenhauser</surname><given-names>G</given-names></name></person-group><article-title>Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity</article-title><source>Journal of Applied Physiology</source><year>1986</year><volume>60</volume><fpage>1917</fpage><lpage>1922</lpage><pub-id pub-id-type="pmid">3087936</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Sayed</surname><given-names>MS</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Rattu</surname><given-names>AJ</given-names></name></person-group><article-title>Blood coagulation and fibrinolysis at rest and in response to maximal exercise before and after a physical conditioning programme</article-title><source>Blood Coagulation &amp; Fibrinolysis</source><year>1995</year><volume>6</volume><fpage>747</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">8825226</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>B</given-names></name><name><surname>Luban</surname><given-names>NL</given-names></name><name><surname>Galioto</surname><given-names>FMJ</given-names></name><name><surname>Rick</surname><given-names>ME</given-names></name><name><surname>Goldstein</surname><given-names>D</given-names></name><name><surname>Kelleher</surname><given-names>JFJ</given-names></name></person-group><article-title>Changes in coagulation parameters with exercise in patients with classic hemophilia</article-title><source>Am J Hematol</source><year>1984</year><volume>16</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">6424436</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiktinsky</surname><given-names>R</given-names></name><name><surname>Falk</surname><given-names>B</given-names></name><name><surname>Heim</surname><given-names>M</given-names></name><name><surname>Martinovitz</surname><given-names>U</given-names></name></person-group><article-title>The effect of resistance training on the frequency of bleeding in haemophilia patients: a pilot study</article-title><source>Haemophilia</source><year>2002</year><volume>8</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">11886461</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2516.2002.00575.x</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilberg</surname><given-names>T</given-names></name><name><surname>Herbsleb</surname><given-names>M</given-names></name><name><surname>Puta</surname><given-names>C</given-names></name><name><surname>Gabriel</surname><given-names>HH</given-names></name><name><surname>Schramm</surname><given-names>W</given-names></name></person-group><article-title>Physical training increases isometric muscular strength and proprioceptive performance in haemophilic subjects</article-title><source>Haemophilia</source><year>2003</year><volume>9</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">12558784</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2516.2003.00679.x</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selvadurai</surname><given-names>HC</given-names></name><name><surname>Blimkie</surname><given-names>CJ</given-names></name><name><surname>Meyers</surname><given-names>N</given-names></name><name><surname>Mellis</surname><given-names>CM</given-names></name><name><surname>Cooper</surname><given-names>PJ</given-names></name><name><surname>Van Asperen</surname><given-names>PP</given-names></name></person-group><article-title>Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><year>2002</year><volume>33</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">11836799</pub-id><pub-id pub-id-type="doi">10.1002/ppul.10015</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>von Mackensen</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Khair</surname><given-names>K</given-names></name><name><surname>Petersen</surname><given-names>C</given-names></name><name><surname>Ravens-Sieberer</surname><given-names>U</given-names></name><name><surname>Rocino</surname><given-names>A</given-names></name><name><surname>Sagnier</surname><given-names>P</given-names></name><name><surname>Tusell</surname><given-names>JM</given-names></name><name><surname>van den Berg</surname><given-names>M</given-names></name><name><surname>Vicariot</surname><given-names>M</given-names></name></person-group><article-title>Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries</article-title><source>Haemophilia</source><year>2002</year><volume>8 Suppl 2</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11966854</pub-id><pub-id pub-id-type="doi">10.1046/j.1351-8216.2001.114.doc.x</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Mackensen</surname><given-names>S</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Haemo-Qo</surname><given-names>LG</given-names></name></person-group><article-title></article-title><source>Haemophilia</source><year>2004</year><volume>10 Suppl 1</volume><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">14987245</pub-id><pub-id pub-id-type="doi">10.1111/j.1355-0691.2004.00875.x</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manco-Johnson</surname><given-names>M</given-names></name><name><surname>Morrissey-Harding</surname><given-names>G</given-names></name><name><surname>Edelman-Lewis</surname><given-names>B</given-names></name><name><surname>Oster</surname><given-names>G</given-names></name><name><surname>Larson</surname><given-names>P</given-names></name></person-group><article-title>Development and validation of a measure of disease-specific quality of life in young children with haemophilia</article-title><source>Haemophilia</source><year>2004</year><volume>10</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">14962218</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2516.2003.00842.x</pub-id></citation></ref><ref id="B14"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>J</given-names></name><name><surname>Atkinson</surname><given-names>SA</given-names></name><name><surname>Halton</surname><given-names>J</given-names></name></person-group><source>An examination of the reliability of the Habitual Activity Estimation Scale (HAES) : Odense, Denmark.
					</source><year>1995</year><fpage>p 49</fpage></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Astermark</surname><given-names>J</given-names></name><name><surname>van der Bom</surname><given-names>JG</given-names></name><name><surname>Ljung</surname><given-names>R</given-names></name><name><surname>Berntorp</surname><given-names>E</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>van den Berg</surname><given-names>HM</given-names></name></person-group><article-title>Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen</article-title><source>Haemophilia</source><year>2002</year><volume>8</volume><fpage>753</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">12410643</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2516.2002.00694.x</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernhardt</surname><given-names>DT</given-names></name><name><surname>Gomez</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>MD</given-names></name><name><surname>Martin</surname><given-names>TJ</given-names></name><name><surname>Rowland</surname><given-names>TW</given-names></name><name><surname>Small</surname><given-names>E</given-names></name><name><surname>LeBlanc</surname><given-names>C</given-names></name><name><surname>Malina</surname><given-names>R</given-names></name><name><surname>Krein</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>JC</given-names></name><name><surname>Reed</surname><given-names>FE</given-names></name><name><surname>Anderson</surname><given-names>SJ</given-names></name><name><surname>Anderson</surname><given-names>SJ</given-names></name><name><surname>Griesemer</surname><given-names>BA</given-names></name><name><surname>Bar-Or</surname><given-names>O</given-names></name><name><surname>Committee on Sports Medicine and</surname><given-names>F</given-names></name></person-group><article-title>Strength training by children and adolescents</article-title><source>Pediatrics</source><year>2001</year><volume>107</volume><fpage>1470</fpage><lpage>1472</lpage><pub-id pub-id-type="pmid">11389279</pub-id><pub-id pub-id-type="doi">10.1542/peds.107.6.1470</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merlini</surname><given-names>L</given-names></name><name><surname>Dell'Accio</surname><given-names>D</given-names></name><name><surname>Granata</surname><given-names>C</given-names></name></person-group><article-title>Reliability of dynamic strength knee muscle testing in children</article-title><source>J Orthop Sports Phys Ther</source><year>1995</year><volume>22</volume><fpage>73</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">7581434</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Unnithan</surname><given-names>VB</given-names></name><name><surname>Murray</surname><given-names>LA</given-names></name><name><surname>Timmons</surname><given-names>JA</given-names></name><name><surname>Buchanan</surname><given-names>D</given-names></name><name><surname>Paton</surname><given-names>JY</given-names></name></person-group><article-title>Reproducibility of cardiorespiratory measurements during submaximal and maximal running in children</article-title><source>Br J Sports Med</source><year>1995</year><volume>29</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">7788223</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wessel</surname><given-names>J</given-names></name><name><surname>Kaup</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Ehalt</surname><given-names>R</given-names></name><name><surname>Ellsworth</surname><given-names>J</given-names></name><name><surname>Speer</surname><given-names>C</given-names></name><name><surname>Tenove</surname><given-names>P</given-names></name><name><surname>Dombrosky</surname><given-names>A</given-names></name></person-group><article-title>Isometric strength measurements in children with arthritis: reliability and relation to function</article-title><source>Arthritis Care Res</source><year>1999</year><volume>12</volume><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">10689988</pub-id><pub-id pub-id-type="doi">10.1002/1529-0131(199908)12:4&lt;238::AID-ART2&gt;3.0.CO;2-I</pub-id></citation></ref></ref-list></back></article>